News > After Russia, US FDA says willing to fast-track Covid vaccine
After Russia, US FDA says willing to fast-track Covid vaccine
India Today | 30/08/2020 09:14 PM | Click to read full article
With Russia approving a Covid vaccine before Phase Three trials, the US Food and Drug Administration (FDA) has said that it is too willing to fast-track a coronavirus vaccine candidate before trials are fully completed. Our emergency use authorization is not the same as a full approval, the US FDA commissioner clarified.
“This is going to be a science, medicine, data decision. This is not going to be a political decision.”